New Data Shed Light on Who Stops Using GLP-1 Drugs, and Why

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

A majority with overweight/obesity discontinue within a year, but the rate is higher among those without type 2 diabetes.
Medscape Medical News